Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 145 of 1,261
  1. US 11865166

    Nucleic acid encoding optimized immunogenic peptide that targets follicle stimulating hormone receptor

    Inovio Pharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  2. US 11866701

    Complement component C3 iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  3. US 11865172

    Materials and methods for respiratory disease control in canines

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  4. US 11865171

    Foot-and-mouth disease vaccine

    United States of America as represented by the Secretary of the Air Force · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  5. US 11866411

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  6. US 11866442

    Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

    NURIX THERAPEUTICS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  7. US 11865117

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  8. US 11865126

    Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

    Compass Pathfinder Limited · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  9. US 11866794

    Cas-ready mouse embryonic stem cells and mice and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  10. US 11866446

    Inhibitors of APOL1 and methods of using same

    Vertex Pharmaceuticals Incorporated · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  11. US 11865179

    Progesterone formulations having a desirable PK profile

    Compass Therapeutics LLC · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  12. US 11866518

    Bicyclic peptide ligands specific for TSLP

    BicycleTx Limited · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  13. US 11865157

    Compositions and methods of targeting cancer stem cells

    The Board of Regents of the University of Texas System · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  14. US 11866709

    Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  15. US 11865174

    Universal vaccine platform

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  16. US 11866450

    Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulators

    Vertex Pharmaceuticals Incorporated · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  17. US 11866418

    Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors

    BioCryst Pharmaceuticals, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  18. US 11865186

    Gene therapy treatment of atrial fibrillation

    Northwestern University · Granted Jan 9, 2024 · Expires Jan 4, 2044

    granted
  19. CA 3260379

    VACCIN CONTRE LE VIRUS D'EPSTEIN-BARR

    BAVARIAN NORDIC AS [DK] · Granted Jan 4, 2024 · Expires Dec 30, 2043

    granted
  20. CA 3258751

    LIGNÉE CELLULAIRE DE MAMMIFÈRE POUR LA PRODUCTION DE VIRUS DE LA VACCINE ANKARA MODIFIÉ (MVA)

    BAVARIAN NORDIC AS [DK] · Granted Jan 4, 2024 · Expires Dec 30, 2043

    granted
  21. CA 3259886

    DISPOSITIFS DE DÉPLACEMENT D'IGE-FCERI

    UNIV AARHUS [DK] · Granted Jan 4, 2024 · Expires Dec 30, 2043

    granted
  22. CA 3260357

    RÉGIME DE PRIMO-IMMUNISATION DE VIRUS DE LA VACCINE ANKARA (MVA) ET DE PETIT ARN ACTIVATEUR (VRP) MODIFIÉS RECOMBINANTS

    BAVARIAN NORDIC AS [DK] · Granted Jan 4, 2024 · Expires Dec 30, 2043

    granted
  23. IT 202200013882

    PRODOTTO DI FERMENTAZIONE PER IL TRATTAMENTO DI MALATTIE INFIAMMATORIE.

    ALFASIGMA SPA [IT] · Granted Jan 4, 2024 · Expires Dec 30, 2043

    granted
  24. US 11857574

    Genetically engineered T cells with Regnase-1 and/or TGFBRII disruption have improved functionality and persistence

    CRISPR THERAPEUTICS AG · Granted Jan 2, 2024 · Expires Dec 28, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.